Cervical Cancer Vaccine
Published on Mar 12 2010, in the categories: Useful info, Vaccination
The vaccine against cervical cancer - The vaccine against cancer of the cervix, Gardasil , Sanofi Pasteur MSD is reimbursed at 65% since July 2007: it is for girls as young as 14 years. The vaccine protects against four strains of HPV, the 16 and 18, responsible for more than 70% of cancers of the cervix and the 6 and 11 officials, they, genital warts.
The aim is to vaccinate 70 to 80% of girls 14 years before their first sexual intercourse to reduce by 70% the risk of cancer of the cervix and 90% of genital warts ... The vaccine may still be offered between 15 and 23 years on condition that young women have not had sexual partners, or at most. Reimbursed by the health insurance: 165 euros per dose and three injections are necessary.
The 2 reminders should be made within 12 months after the 1st injection. They are generally recommended the 2nd month and 6th month. The vaccine does not protect against all carcinogenic HPV, or against existing infections. The smear is essential: The remains of screening for women 25 to 65 is necessary in parallel to vaccination because the vaccine does not replace the Pap smear.
HPV virus test detects a risk of cervical dysplasia or presence of cancer in cases of permanent presence of HPV. The risk appears to be rejected for the 5 or 10 years later if the test is negative. Repeat this test every 5 years.
Screening for cervical cancer - The prevention of cervical cancer of the uterus is still primarily the detection of precancerous and cancerous lesions caused by human papillomavirus. It is based on the regular practice of a smear that by collecting cervical cells allows their analysis under the microscope.
The smear - The smear can examine the cells of the cervix under a microscope and to gather the most superficial. The sample is then spread and fixed on a glass slide. The sample is sent to a laboratory anapathologie which will search for abnormal cells.
Screening for cervical cancer of the uterus is at the age of 20/25 years. It is recommended that a smear every 3 years after 2 normal smears obtained one year apart in women with sexual activity and this from 20-25 years. But the 3-year interval recommended is too long for many specialists. A period of 2 years now seems advisable. The infection is common in women, the early sex. The risk of infection increases with age and number of partners. The use of condoms during sexual intercourse limit transmission of the virus but does not eliminate it completely from all contact, because it is present at the genital mucosa are not covered by the condom.
The aim is to vaccinate 70 to 80% of girls 14 years before their first sexual intercourse to reduce by 70% the risk of cancer of the cervix and 90% of genital warts ... The vaccine may still be offered between 15 and 23 years on condition that young women have not had sexual partners, or at most. Reimbursed by the health insurance: 165 euros per dose and three injections are necessary.
The 2 reminders should be made within 12 months after the 1st injection. They are generally recommended the 2nd month and 6th month. The vaccine does not protect against all carcinogenic HPV, or against existing infections. The smear is essential: The remains of screening for women 25 to 65 is necessary in parallel to vaccination because the vaccine does not replace the Pap smear.
HPV virus test detects a risk of cervical dysplasia or presence of cancer in cases of permanent presence of HPV. The risk appears to be rejected for the 5 or 10 years later if the test is negative. Repeat this test every 5 years.
Screening for cervical cancer - The prevention of cervical cancer of the uterus is still primarily the detection of precancerous and cancerous lesions caused by human papillomavirus. It is based on the regular practice of a smear that by collecting cervical cells allows their analysis under the microscope.
The smear - The smear can examine the cells of the cervix under a microscope and to gather the most superficial. The sample is then spread and fixed on a glass slide. The sample is sent to a laboratory anapathologie which will search for abnormal cells.
Screening for cervical cancer of the uterus is at the age of 20/25 years. It is recommended that a smear every 3 years after 2 normal smears obtained one year apart in women with sexual activity and this from 20-25 years. But the 3-year interval recommended is too long for many specialists. A period of 2 years now seems advisable. The infection is common in women, the early sex. The risk of infection increases with age and number of partners. The use of condoms during sexual intercourse limit transmission of the virus but does not eliminate it completely from all contact, because it is present at the genital mucosa are not covered by the condom.
If you liked this post, subscribe to our blog by filling your e-mail address below:
Want to add something? Post your comments